Top

Published in:

Open Access 01-12-2022 | Toxoplasmosis | Research

Utility of blood as the clinical specimen for the diagnosis of ocular toxoplasmosis using uracil DNA glycosylase-supplemented loop-mediated isothermal amplification and real-time polymerase chain reaction assays based on REP-529 sequence and B1 gene

Authors: Bahman Rahimi Esboei, Shirzad Fallahi, Mohammad Zarei, Bahram Kazemi, Mehdi Mohebali, Saeedeh Shojaee, Parisa Mousavi, Aref Teimouri, Raziyeh Mahmoudzadeh, Mirataollah Salabati, Hossein Keshavarz Valian

Published in: BMC Infectious Diseases | Issue 1/2022

Abstract

Background

Ocular infection with Toxoplasma gondii is a major preventable cause of blindness, especially in young people. The aim of the present study was to assess detection rate of T. gondii DNA in blood samples of clinically diagnosed of ocular toxoplasmosis using uracil DNA glycosylase-supplemented loop-mediated isothermal amplification (UDG-LAMP) and real-time quantitative PCR (qPCR) based on REP-529 and B1.

Methods

One hundred and seventeen patients with clinically diagnosed ocular toxoplasmosis (OT) were participated in the study as well as 200 control patients. Peripheral blood samples were assessed using UDG-LAMP and qPCR techniques targeting REP-529 and B1.

Results

Detection limits of qPCR using REP-529 and B1 were estimated as 0.1 and 1 fg of T. gondii genomic DNA, respectively. The limits of detection for UDG-LAMP using REP-529 and B1 were 1 and 100 fg, respectively. In this study, 18 and 16 patients were positive in qPCR using REP-529 and B1, respectively. Based on the results of UDG-LAMP, 15 and 14 patients were positive using REP-529 and B1, respectively. Results of the study on patients with active ocular lesion showed that sensitivity of REP-529 and BI targets included 64 and 63%, respectively using qPCR. Sensitivity of 62 and 61%, were concluded from UDG-LAMP using REP-529 and B1 in the blood cases of active ocular lesion. qPCR was more sensitive than UDG-LAMP for the detection of Toxoplasma gondii DNA in peripheral blood samples of patients with clinically diagnosed toxoplasmic chorioretinitis. Furthermore, the REP-529 included a better detection rate for the diagnosis of ocular toxoplasmosis in blood samples, compared to that the B1 gene did. Moreover, the qPCR and UDG-LAMP specificity assessments have demonstrated no amplifications of DNAs extracted from other microorganisms based on REP-529 and B1.

Conclusions

Data from the current study suggest that qPCR and UDG-LAMP based on the REP-529 are promising diagnostic methods for the diagnosis of ocular toxoplasmosis in blood samples of patients with active chorioretinal lesions.

Silveira C, Belfort R Jr, Burnier M Jr, Nussenblatt R. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol. 1988;106(3):362–4.PubMed

Nussenblatt RB, Belfort R Jr. Ocular toxoplasmosis. An old disease revisited. JAMA. 1994;271(4):304–7.PubMed

Silveira C, Ferreira R, Muccioli C, Nussenblatt R, Belfort R Jr. Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. Am J Ophthalmol. 2003;136(2):370–1.PubMed

Shojaee S, Teimouri A, Keshavarz H, Azami SJ, Nouri S. The relation of secondary sex ratio and miscarriage history with Toxoplasma gondii infection. BMC Infect Dis. 2018;18(1):307. https://doi.org/10.1186/s12879-018-3228-0. PMID: 29976155; PMCID: PMC6034284.CrossRefPubMedPubMedCentral

Teimouri A, Mohtasebi S, Kazemirad E, Keshavarz H. Role of Toxoplasma gondii IgG avidity testing in discriminating between acute and chronic toxoplasmosis in pregnancy. J Clin Microbiol. 2020;58(9):e00505–20. https://doi.org/10.1128/JCM.00505-20. PMID: 32321784; PMCID: PMC7448626.CrossRefPubMedPubMedCentral

Johnson MW, Greven CM, Jaffe GJ, Sudhalkar H, Vine AK. Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology. 1997;104:48–57.PubMed

Fardeau C, Romand S, Rao NA, Cassoux N, Bettembourg O, Thulliez P, et al. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol. 2002;134:196–203.PubMed

Stanford MR, Gras L, Wade A, Gilbert RE. Reliability of expert interpretation of retinal photographs for the diagnosis of Toxoplasma retinochoroiditis. Br J Ophthalmol. 2002;86:636–9.PubMedPubMedCentral

Ali-Heydari S, Keshavarz H, Shojaee S, Mohebali M. Diagnosis of antigenic markers of acute toxoplasmosis by IgG avidity immunoblotting. Parasite. 2013;20:18. https://doi.org/10.1051/parasite/2013017. PMID: 23688778; PMCID: PMC3718541.CrossRefPubMedPubMedCentral

10.

Montoya JG, Parmley S, Liesenfeld O, Jaffe GJ, Remington JS. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. Ophthalmology. 1994;106:1554–63.

11.

Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002;185(Suppl 1):e73e82.

12.

Garweg JG, Jacquier P, Boehnke M. Early aqueous humor analysis in patients with human ocular toxoplasmosis. J Clin Microbiol. 2000;38:996–1001.PubMedPubMedCentral

13.

Park YH, Nam HW. Clinical features and treatment of ocular toxoplasmosis. Korean J Parasitol. 2013;51(4):393–9.PubMedPubMedCentral

14.

Greigert V, Foggia ED, Filisetti D, Villard O, Pfaff AW, Sauer A, Candolfi E. When biology supports clinical diagnosis: review of techniques to diagnose ocular toxoplasmosis. Br J Ophthalmol. 2019;103:1008–12.PubMed

15.

de-la-Torre A, Valdés-Camacho J, de Mesa CL, Uauy-Nazal A, Zuluaga JD, et al. Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin. BMC Infect Dis. 2019;19:91.PubMedPubMedCentral

16.

Contini C, Seraceni S, Cultrera R, Incorvaia C, Sebastiani A, Picot S. Evaluation of a real-time PCR-based assay using the lightcycler system for detection of Toxoplasma gondii bradyzoite genes in blood specimens from patients with toxoplasmic retinochoroiditis. Int J Parasitol. 2005;35:275–83.PubMed

17.

Kompalic-Cristo A, Frotta C, Suárez-Mutis M, Fernandes O, Britto C. Evaluation of a real-time PCR assay based on the repetitive B1 gene for the detection of Toxoplasma gondii in human peripheral blood. Parasitol Res. 2007;101(3):619–25.PubMed

18.

Mousavi P, Mirhendi H, Mohebali M, Shojaee S, Keshavarz Valian H, Fallahi S, Mamishi S. Detection of Toxoplasma gondii in acute and chronic phases of infection in immunocompromised patients and pregnant women with real-time PCR assay using TaqMan fluorescent probe. Iran J Parasitol. 2018;13(3):373–81. PMID: 30483328; PMCID: PMC6243173.PubMedPubMedCentral

19.

Obande GA, Singh KKB. Current and future perspectives on isothermal nucleic acid amplification technologies for diagnosing infections. Infect Drug Resist. 2020;13:455–83.PubMedPubMedCentral

20.

Braakenburg A, Rothova A. Advances in ocular toxoplasmosis. In: Uveitis: an update. Cham: Springer; 2016. p. 1–7.

21.

Grigg ME, Dubey JP, Nussenblatt RB. Ocular toxoplasmosis: lessons from Brazil. Am J Ophthalmol. 2015;159:999–1001.PubMedPubMedCentral

22.

Vasconcelos-Santos DV. Ocular toxoplasmosis. In: Rao N, Schallhorn J, Rodger D, editors. Posterior uveitis. Essentials in ophthalmology. Cham: Springer; 2019. https://doi.org/10.1007/978-3-030-03140-4_5.CrossRef

23.

Jones JL, Bonetti V, Holland GN, Press C, Sanislo SR, Khurana RN, Montoya JG. Ocular toxoplasmosis in the United States: recent and remote infections. Clin Infect Dis. 2015;60:271–3.PubMed

24.

Rahimi-Esboei B, Zarei M, Mohebali M, Valian HK, Shojaee S, Mahmoudzadeh R, Salabati M. Serologic tests of IgG and IgM antibodies and IgG avidity for diagnosis of ocular toxoplasmosis. Korean J Parasitol. 2018;56(2):147–52. https://doi.org/10.3347/kjp.2018.56.2.147. PMID: 29742869; PMCID: PMC5976017.CrossRefPubMedPubMedCentral

25.

Rahimi Esboei B, Kazemi B, Zarei M, Mohebali M, Keshavarz Valian H, Shojaee S, Zahedipour F, Fallahi S, Mousavi P, Mahmoudzadeh R, Salabati M. Evaluation of RE and B1 genes as targets for detection of Toxoplasma gondii by nested PCR in blood samples of patients with ocular toxoplasmosis. Acta Parasitol. 2019;64(2):384–9. https://doi.org/10.2478/s11686-019-00056-6. PMID: 31020496.CrossRefPubMed

26.

Azami SJ, Teimouri A, Keshavarz H, Amani A, Esmaeili F, Hasanpour H, Elikaee S, Salehiniya H, Shojaee S. Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice. Int J Nanomed. 2018;13:7363–74. https://doi.org/10.2147/IJN.S181896. PMID: 30519020; PMCID: PMC6233476.CrossRef

27.

Homan WL, Vercammenb M, De Braekeleer J, Verschueren H. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Inter J Parasitol. 2000;30:69-75.30.

28.

Burg JL, Grover CM, Pouletty P, Boothroyd JC. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol. 1989;27:1787–92.PubMedPubMedCentral

29.

Keshavarz Valian H, Mirhendi H, Mohebali M, Shojaee S, Fallahi S, et al. Comparison of the RE-529 sequence and B1 gene for Toxoplasma gondii detection in blood samples of the at-risk seropositive cases using uracil DNA glycosylase supplemented loop-mediated isothermal amplification (UDG-LAMP) assay. Microb Pathog. 2020;140:103938. https://doi.org/10.1016/j.micpath.2019.103938. PMID: 31862390.CrossRef

30.

Fallahi S, Moosavi SF, Karimi A, Chegeni AS, Saki M, et al. An advanced uracil DNA glycosylase-supplemented loop-mediated isothermal amplification (UDG-LAMP) technique used in the sensitive and specific detection of Cryptosporidium parvum, Cryptosporidium hominis, and Cryptosporidium meleagridis in AIDS patients. Diagn Microbiol Infect Dis. 2018;91:6–12.PubMed

31.

Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611–22.PubMed

32.

Camilo LM, Pereira-Chioccola VL, Gava R, Meira-Strejevitch CDS, Vidal JE, Brandão de Mattos CC, Frederico FB, De Mattos LC, Spegiorin LCJF, FAMERP Toxoplasma Research Group. Molecular diagnosis of symptomatic toxoplasmosis: a 9-yearretrospective and prospective study in a referral laboratory in São Paulo, Brazil. Braz J Infect Dis. 2017;21(6):638–47.PubMed

33.

Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285–93. https://doi.org/10.1126/science.3287615.CrossRefPubMed

34.

Ozgonul C, Besirli CG. Recent developments in the diagnosis and treatment of ocular toxoplasmosis. Ophthalmic Res. 2017;57:1–12.PubMed

35.

Gómez Marín JE, Zuluaga JD, Pechené Campo EJ, Triviño J, De-la-Torre A. Polymerase chain reaction (PCR) in ocular and ganglionar toxoplasmosis and the effect of therapeutics for prevention of ocular involvement in South American setting. Acta Trop. 2018;184:83–7.PubMed

36.

Garcia JL, Burrells A, Bartley PM, Bartley K, Innes EA, Katzer F. The use of ELISA, nPCR and qPCR for diagnosis of ocular toxoplasmosis in experimentally infected pigs. Vet Sci Res J. 2017;115:490–5.

37.

Bou G, Figueroa MS, Martí-Belda P, Navas E, Guerrero A. Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis. J Clin Microbiol. 1999;37:3465–8.PubMedPubMedCentral

38.

Khanaliha K, Hedayatfar A, Minaeian S, Bokharaei-Salim F, Alemzadeh SA, Garshasbi S, FagheeiAghmiyuni Z, Salemi B. Detection of Toxoplasma gondii bradyzoite genes in the peripheral blood mononuclear cells among patients with toxoplasmic chorioretinitis. Trans R Soc Trop Med Hyg. 2021;Apr13:trab062.

39.

Bourdin C, Busse A, Kouamou E, Touafek F, Bodaghi B, et al. PCR-based detection of Toxoplasma gondii DNA in blood and ocular samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol. 2014;52:3987–91.PubMedPubMedCentral

40.

Amendoeira MR, Coutinho SG. Isolation of Toxoplasma gondii from the saliva and tonsils of a three-year-old child. J Infect Dis. 1982;145:587.PubMed

41.

Silveira C, Vallochi AL, da Silva UR, Muccioli C, Holland GN, et al. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol. 2011;95:396–400.PubMed

42.

Kong QM, Lu SH, Tong QB, Lou D, Chen R, Zheng B, Kumagai T, Wen LY, Ohta N, Zhou XN. Loop-mediated isothermal amplification (LAMP): early detection of Toxoplasma gondii infection in mice. Parasit Vectors. 2012;5:2–7.PubMedPubMedCentral

43.

Zhang H, Thekisoe OM, Aboge GO, Kyan H, Yamagishi J, Inoue N, Nishikawa Y, Zakimi S, Xuan X. Toxoplasma gondii: sensitive and rapid detection of infection by loop-mediated isothermal amplification (LAMP) method. Exp Parasitol. 2009;122:47–50.PubMed

44.

Selseleh MM, Keshavarz H, Mohebali M, Shojaee S, Modarressi M, Eshragian M, Selseleh MM. Production and evaluation of Toxoplasma gondii recombinant surface antigen 1 (SAG1) for serodiagnosis of acute and chronic toxoplasma infection in human sera. Iran J Parasitol. 2012;7(3):1–9. PMID: 23109955; PMCID: PMC3469165.PubMed

45.

Selseleh M, Keshavarz H, Mohebali M, Shojaee S, Selseleh M, Eshragian MR, Mansouri F, Modarressi MH. Production and evaluation of Toxoplasma gondii recombinant GRA7 for serodiagnosis of human infections. Korean J Parasitol. 2012;50(3):233–8. https://doi.org/10.3347/kjp.2012.50.3.233. PMID: 22949752; PMCID: PMC3428570.CrossRefPubMedPubMedCentral

46.

Holec-Gasior L. Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis—the current status of studies. Clin Vaccine Immunol. 2013;20(9):1343–51.PubMedPubMedCentral

47.

Teimouri A, Modarressi MH, Shojaee S, Mohebali M, Rezaian M, Keshavarz H. Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections. Infect Drug Resist. 2019;12:2657–2669. https://doi.org/10.2147/IDR.S219281. PMID: 31695442; PMCID: PMC6717716.CrossRefPubMedPubMedCentral

48.

Teimouri A, Abbaszadeh Afshar MJ, Mohtasebi S, Jafarpour Azami S, Alimi R, Keshavarz H. Assessment of an in-house enzyme-linked immunosorbent assay and IgG avidity test based on SAG1 and GRA7 proteins for discriminating between acute and chronic toxoplasmosis in humans. J Clin Microbiol. 2021;59(8):e0041621. https://doi.org/10.1128/JCM.00416-21. PMID: 34077255; PMCID: PMC8288279.CrossRefPubMed

49.

Cassaing S, Bessières M, Berry A, Berrebi A, Fabre R, Magnaval J. Comparison between two amplification sets for molecular diagnosis of toxoplasmosis by real-time PCR. J Clin Microbiol. 2006;44:720–4.PubMedPubMedCentral

50.

Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25:264–96.PubMedPubMedCentral

51.

da Silva RC, Langoni H, Su C, da Silva AV. Genotypic characterization of Toxoplasma gondii in sheep from Brazilian slaughterhouses: new atypical genotypes and the clonal type II strain identified. Vet Parasitol. 2011;175:173–7.PubMed

52.

Okay TS, Yamamoto L, Oliveira LC, Manuli ER, Andrade Junior HFD, Del Negro GMB. Significant performance variation among PCR systems in diagnosing congenital toxoplasmosis in São Paulo, Brazil: analysis of 467 amniotic fluid samples. Clinics. 2009;64:171–6.PubMedPubMedCentral

53.

Correia CC, Melo HR, Costa VM. Influence of neurotoxoplasmosis characteristics on real-time PCR sensitivity among AIDS patients in Brazil. Trans R Soc Trop Med Hyg. 2010;104:24–8.PubMed

54.

Buchbinder S, Blatz R, Rodloff AC. Comparison of real-time PCR detection methods for B1 and P30 genes of Toxoplasma gondii. Diagn Microbiol Infect Dis. 2003;45:269–71.PubMed

55.

Ossorio PN, Sibley LD, Boothroyd JC. Mitochondrial-like DNA sequences flanked by direct and inverted repeats in the nuclear genome of Toxoplasma gondii. J Mol Biol. 1991;222:525–36.PubMed

56.

Notomi T, Hiroto O, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000. https://doi.org/10.1093/nar/28.12.e63.CrossRefPubMedPubMedCentral

Title: Utility of blood as the clinical specimen for the diagnosis of ocular toxoplasmosis using uracil DNA glycosylase-supplemented loop-mediated isothermal amplification and real-time polymerase chain reaction assays based on REP-529 sequence and B1 gene
Authors: Bahman Rahimi Esboei
Shirzad Fallahi
Mohammad Zarei
Bahram Kazemi
Mehdi Mohebali
Saeedeh Shojaee
Parisa Mousavi
Aref Teimouri
Raziyeh Mahmoudzadeh
Mirataollah Salabati
Hossein Keshavarz Valian
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Toxoplasmosis
Polymerase Chain Reaction
Published in: BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-022-07073-3

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Utility of blood as the clinical specimen for the diagnosis of ocular toxoplasmosis using uracil DNA glycosylase-supplemented loop-mediated isothermal amplification and real-time polymerase chain reaction assays based on REP-529 sequence and B1 gene

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Clinical features and risk factors of surgical site infections in HIV-negative patients with cryptococcal meningitis underwent ventriculoperitoneal shunt operations: a retrospective study

Prehospital norepinephrine administration reduces 30-day mortality among septic shock patients

Facilitators and barriers to COVID-19 vaccination among healthcare workers and the general population in Guinea

Developing strategies to address barriers for tuberculosis case finding and retention in care among refugees in slums in Kampala, Uganda: a qualitative study using the COM-B model

Disseminated talaromycosis complicated by recurrent gastrointestinal bleeding and hemorrhagic shock: a case report

Trends and effects of antiretroviral therapy coverage during pregnancy on mother-to-child transmission of HIV in Sub-Saharan Africa. Evidence from panel data analysis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page